|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Crystal size distribution in continuous crystallizer when growth rate is size-dependent 显示文摘 | Abegg C F Stevens J D Larson M A | 1968 | AIChE J1968，14，： | 1 |
| 2 | The impact of oral health on daily perform- ance of municipal waste disposal workers in Porto Alegre, Rio Grande do Sul State, Brazil 显示文摘 | GOMES AS ABEGG C | 2007 | Cad Saude Publica2007，23，7： | 1 |
| 3 | Treatment of branch retinal vein occlusion induced macular edema with bevacizumab显示文摘 | ABEGG M TAPPEINER C WOLF-SCHNURRBUSCH U | 2008 | BMC Ophthalmol2008，8，1： | 1 |
| 4 | Learning curves of theGlidescope, the McGrath and the Airtraq laryngoscopes : a manikin study 显示文摘 | Savoldelli GL Schifer E Abegg C | 2009 | Eur J Anaesthesiol2009，26，7： | 1 |
| 5 | Crystal size distribution in continuous crystallizer when growth rate is size-dependent显示文摘 | ABEGG C F STEVENS J D LARSON M A | 1968 | AIChE J1968，14，： | 1 |
| 6 | Treatment of branch retinal vein occlusion induced macular edema with bevacizumab显示文摘 | Abegg M Tappe Iner C Wolf-schnurrbusch U | | 0，，： | 1 |
| 7 | Crystal size distributions in continuous crystallizers when growth rate is sizedependent显示文摘 | Abegg C F Stevens J D Larson M A | 1968 | AICHE1968，14，1： | 1 |
| 8 | Learning curves of the gGlidescope, the McGrath and the Airtraq laryngoscopes: a mani- kin study显示文摘 | Savoldelli GL Schiffer E Abegg C | 2009 | Eur J Anaesthesiol2009，26，7： | 1 |
| 9 | Treatment of branch retinal vein occlusion in- duced macular edema with bavacizumab 显示文摘 | Abegg M Tappeiner C Wolf-schnurrbusch U Barthelmes D Wolf S Fleischhauer J | 2008 | BMC Ophthalmol2008，8，9： | 1 |
| 10 | Learning curves of the Glidescope, the McGrath and the Airtraq laryngoscopes: a manikin study显示文摘 | Savoldelli GL Schiffer E Abegg C | 2009 | Eur J Anaesthesiol2009，26，7： | 1 |
| 11 | The impact of oral health on daily per- formance of municipal waste disposal workers in Porto Alegre, Rio Grande do Sul State, Brazil 显示文摘 | Gomes AS Abegg C | 2007 | Cad Saude Publica2007，23，7： | 1 |
| 12 | Treatment of branch retinal vein occlusion induced macular edema with bevacizumab显示文摘 | Abegg M Tappeiner C Wolf-Schnuurrbusch U | 2008 | BMC Ophthalmo12008，8，1： | 1 |
| 13 | 显示文摘 | Stevens J D Larson M A | 1968 | AIChE J1968，14，： | 1 |
| 14 | Treatnent of branch retinal vein occlusion induced macular edema with bevacizumab显示文摘 | Abegg M Tappeiner C Wolf-Schnurrbusch U | 2008 | BMC Ophthalmol2008，8，： | 1 |
| 15 | Treatment of branch retinal vein occlusion induced macular edema with bevacizumab 显示文摘 | Abegg M Tappeiner C Wolf-Schnurrbusch U Barthelmes D Wolf S Fleischhauer J | 2008 | BMC Ophthalmol2008，8，： | 1 |
| 16 | Comparison of the Glidescope,the McGrath,the Airtraq and the Macintosh laryngoscopes in simulated difficult airways显示文摘 | Savoldelli GL Schiffer E Abegg C | 2008 | Anaesthesia2008，63，12： | 1 |
| 17 | Sensitivity of Arctic climate simulations to different boundary layer parameterizations in a regional climate model显示文摘 | DETHLOFF K ABEGG C RINKE A | 2001 | Tellus2001，53，： | 1 |
| 18 | Buddy Study: Partners for better health in adolescents with type 2 diabetes显示文摘AIM: To investigate whether assigning young, healthy and motivated lay volunteer partners('buddies') to adolescents with type 2 diabetes improves hemoglobin A1c(HbA 1c). METHODS: Adolescents with type 2 diabetes were randomized to partnering with a 'buddy' or to conventional treatment. During the initial screening visit, which coincided with a routine outpatient diabetes clinic visit, patients with type 2 diabetes underwent a physical examination, detailed medical history, laboratory measurement of HbA 1c, and completed two questionnaires(Pediatric Quality of Life Inventory and Children's Depression Inventory) to assess their overall quality of life and the presence of depressive symptoms. Patients were then randomized to the intervention(the buddy system) or conventional treatment(standard care). All patients were scheduled to return for followup at 3- and 6-mo after their initial visit. Hb A1 c was determined at all visits(i.e., at screening and at the 3- and 6-mo follow-up visits) and quality of life and depressive symptoms were evaluated at the screening visit and were reassessed at the 6-mo visit. RESULTS: Ten adolescents, recruited from a pool of approximately 200 adolescents, enrolled over a twoyear time period, leading to premature termination of the study. In contrast, we easily recruited motivated lay volunteers. We found no change in HbA 1c from the initial to the 6-mo visit in either group, yet our small sample size limited systematic assessment of this outcome. Participants repeatedly missed clinic appointments, failed to conduct self-glucose-monitoring and rarely brought their glucometers to clinic visits. Total quality of life scores(72.6 ± 6.06) at screening were similar to previously reported scores in adolescents with type 2 diabetes(75.7 ± 15.0) and lower than scores reported in normal-weight(81.2 ± 0.9), overweight(83.5 ± 1.8), and obese youths without diabetes(78.5 ± 1.8) or in adolescents with type 1 diabetes(80.5 ± 13.1). Among adolescents who returned for their 6-mo visit, there were no differences in total quality of life scores(70.2 ± 9.18) between screening and follow-up.CONCLUSION: Our approach, effective in adults with type 2 diabetes, was unsuccessful among adolescents and emphasizes the need for innovative strategies for diabetes treatment in adolescent patients. | Allison C Sylvetsky Radha Nandagopal Tammy T Nguyen Marisa R Abegg Mahathi Nagarur Paul Kaplowitz Kristina I Rother | 2015 | World Journal of Diabetes2015，6，18： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员